CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 108 enrolled
Drug / intervention
Eso-SPONGE® vacuum treatmentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02662777
NCT02662777N/ACompleted
CompareCT.gov

International, Prospective, Multicenter Registry Designed to Collect Clinical Evidence for Endoscopic Vacuum Treatment Using Eso-SPONGE® for Anastomotic Leakage After Esophageal Resection or Iatrogenic or Spontaneous Esophageal Perforation.

Aesculap AG·observational·Posted Jan 26, 2016·Updated Aug 14, 2024

In Brief

An observational study evaluating Eso-SPONGE® vacuum treatment for Leakage After Esophagectomy and 2 related conditions. Completed, enrolled 108 participants across 17 sites.

Detailed Summary

This international, prospective and multicenter registry was designed to collect clinical evidence for the endoscopic vacuum treatment using Eso-SPONGE® for anastomotic leakage after esophageal resection or iatrogenic or spontaneous esophageal perforation.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLeakage After Esophagectomy, Leakage After Gastrectomy, Perforation of the Esophagus
CountriesGermany
CollaboratorsUniversity of Kiel

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJan 26, 2016
Enrollment StartJan 1, 2015
Primary CompletionDec 31, 2023
TodayJul 2, 2026
Enrollment to primary: 9 yearsPosted 10.4 years ago

Interventions

Eso-SPONGE® vacuum treatmentdevice